*Authors/Writing Committee of the Fibrinogen Studies
Collaboration: John Danesh, DPhil, Department of Public Health and
Primary Care, University of Cambridge, Cambridge, England; Sarah Lewington,
DPhil, Clinical Trial Service Unit, University of Oxford, Oxford, England;
Simon G. Thompson, DSc, Medical Research Council Biostatistics Unit, Institute
of Public Health, Cambridge, England; Gordon D. O. Lowe, FRCP, Division of
Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland;
Rory Collins, FMedSci, Clinical Trial Service Unit, University of Oxford,
Oxford, England.
Authors/Members of the Fibrinogen Studies Collaboration:AMIS: J. B. Kostis, A. C. Wilson. Atherosclerosis Risk in Communities Study: A. R. Folsom, K. Wu. BIP Registry: M. Benderly, U. Goldbourt. Bruneck Study: J. Willeit, S. Kiechl. Caerphilly
Study: J. W. G. Yarnell, P. M. Sweetnam, P. C. Elwood (this prospective
cohort study was undertaken by the former UK Medical Research Council Epidemiology
Unit [South Wales] and was funded by the Medical Research Council/Institute
of Public Health; its data archive is maintained by the Department of Social
Medicine, University of Bristol). Cardiovascular Health
Study: M. Cushman, B. M. Psaty, R. P. Tracy (see http://chs-nhlbi.org for acknowledgments). Copenhagen City Heart Study: A. Tybjærg-Hansen. ECAT Angina Pectoris Study: F. Haverkate, M. P. M. de Maat, S. G. Thompson. Edinburgh Artery Study & Edinburgh Claudication Study: F. G. R.
Fowkes, A. J. Lee, F. B. Smith. FINRISK 1992 Hemostasis
Study: V. Salomaa, K. Harald, V. Rasi, E. Vahtera, P. Jousilahti, J.
Pekkanen. Framingham Study: R. D’Agostino,
W. B. Kannel, P. W. F. Wilson, G. Tofler. FRECVE:
C. L. Arocha-Piñango, A. Rodriguez-Larralde, E. Nagy, M. Mijares, R.
Espinosa, E. Rodriquez-Roa, E. Ryder, M. P. Diez-Ewald, G. Campos, V. Fernandez,
E. Torres, E. Coll. GISSI Prevenzione: R. Marchioli,
F. Valagussa. Göteborg 1913 & Göteborg 1933: A. Rosengren, L. Wilhelmsen, G. Lappas, H. Eriksson. GRIPS Study: P. Cremer, D. Nagel. Honolulu Heart
Program: J. D. Curb, B. Rodriguez, K. Yano. Kuopio
IHD Study: J. T. Salonen, K. Nyyssönen, T.-P. Tuomainen. Malmö: B. Hedblad, P. Lind. MONICA/KORA-Augsburg: H. Loewel, W. Koenig. Northwick Park Heart Study
I: T. W. Meade, J. A. Cooper, B. De Stavola, C. Knottenbelt. Northwick Park Heart Study II: G. J. Miller, J. A. Cooper,
K. A. Bauer, R. D. Rosenberg. Osaka Study: S. Sato,
A. Kitamura, Y. Naito, H Iso. Platelet Activation and Inflammation
Study: V. Salomaa, K. Harald, V. Rasi, E. Vahtera, P. Jousilahti, T.
Palosuo. PRIME Study: P. Ducimetiere, P. Amouyel,
D. Arveiler, A. E. Evans, J. Ferrieres, I. Juhan-Vague, A. Bingham. PROCAM Study: H. Schulte, G. Assmann. Quebec Cardiovascular Study: B. Cantin, B. Lamarche, J.-P. Després,
G. R. Dagenais. Scottish Heart Health Study: H. Tunstall-Pedoe,
G. D. O. Lowe, M. Woodward. Speedwell: Y. Ben-Shlomo,
G. Davey Smith. Strong Heart Study: V. Palmieri,
J. L. Yeh. Thrombosis Prevention Trial: T. W. Meade,
A. Rudnicka, C. Knottenbelt, J. A. Cooper. US Physicians
Health Study: P. Ridker. VITA: F. Rodeghiero,
A. Tosetto. West of Scotland Coronary Prevention Study:
J. Shepherd, G. D. O. Lowe, I. Ford, M. Robertson. Whitehall
II: E. Brunner, M. Shipley. Zutphen Elderly Study: E. J. M. Feskens, D. Kromhout.
Authors/Independent Statistical Analyses/Secretariat: Data
management and statistical analyses were supervised and conducted by the following
team of academic epidemiologists, statisticians, programmers, and data managers:
R. Collins, J. Danesh (coordinator and corresponding author), A. Dickinson,
B. Ireland, K. Juzwishin, S. Kaptoge, S. Lewington, G. D. O. Lowe, A. Memon,
N. Sarwar, S. G. Thompson, M. Walker, J. Wheeler, I. White, A. Wood.
Other Members of the Fibrinogen Studies Collaboration: P. Brennan, L. Chambless, H.
W. Hense, D. Levy.